SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Danaher Corporation (DHR-PB) trades at a trailing P/E of 250.3. Trailing earnings yield is 0.40%.
Criteria proven by this page:
- VALUE (15/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 250.3); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY 0.40%).
- Trailing Earnings Yield 0.40% — below bond yields — investors are paying a premium for expected growth rather than current earnings.
Overall SharesGrow Score: 62/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
15/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — DHR-PB
Valuation Multiples
P/E (TTM)250.3
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio36.50
EV/EBITDA0.0
Per Share Data
EPS (TTM)$5.04
Book Value / Share$0.00
Revenue / Share$34.55
FCF / Share$0.00
Yields & Fair Value
Earnings Yield0.40%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$3.65 |
$16.88B |
$2.55B |
15.1% |
| 2017 |
$3.53 |
$18.33B |
$2.49B |
13.6% |
| 2018 |
$3.73 |
$19.89B |
$2.65B |
13.3% |
| 2019 |
$3.43 |
$17.91B |
$3.01B |
16.8% |
| 2020 |
$4.89 |
$22.28B |
$3.65B |
16.4% |
| 2021 |
$8.61 |
$29.45B |
$6.43B |
21.8% |
| 2022 |
$9.64 |
$31.47B |
$7.21B |
22.9% |
| 2023 |
$6.38 |
$23.89B |
$4.76B |
19.9% |
| 2024 |
$5.29 |
$23.88B |
$3.9B |
16.3% |
| 2025 |
$5.04 |
$24.57B |
$3.61B |
14.7% |
